EMCOR Group (EME) Misses Q4 EPS by 7c
Get Alerts EME Hot Sheet
Price: $748.33 -0.79%
Revenue Growth %: +20.7%
Financial Fact:
Restructuring expenses: 539K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +20.7%
Financial Fact:
Restructuring expenses: 539K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
EMCOR Group (NYSE: EME) reported Q4 EPS of $0.68, $0.07 worse than the analyst estimate of $0.75. Revenue for the quarter came in at $1.71 billion versus the consensus estimate of $1.67 billion.
Backlog as of December 31, 2014 was $3.63 billion, an increase of 8.7% from $3.34 billion at the end of the 2013 fourth quarter.
For earnings history and earnings-related data on EMCOR Group (EME) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Champions Oncology (CSBR) Tops Q1 EPS by 6c
- Oracle raises full year profit guidance, stock rises after hours
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share